5-lipoxygenase-activating protein inhibitor

Details for Australian Patent Application No. 2009325091 (hide)

Owner Amira Pharmaceuticals, Inc.

Inventors Schaab, Kevin Murray; King, Christopher David; Stock, Nicholas Simon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009325091

PCT Pub. Number WO2010/068311

Priority 61/055,887 23.05.08 US; 61/055,899 23.05.08 US

Filing date 22 May 2009

Wipo publication date 17 June 2010

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/437 (2006.01)

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2010/068311 Priority application(s): WO2010/068311

10 November 2011 Assignment before Grant

  Amira Pharmaceuticals, Inc. The application has been assigned to Panmira Pharmaceuticals, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009325099-Tie-plate and frame hanger of a suspension assembly

2009325088-Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease